Body interventional procedures: which is the best method for CT guidance?


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 09 09 2019
accepted: 09 10 2019
revised: 25 09 2019
pubmed: 30 11 2019
medline: 1 9 2020
entrez: 29 11 2019
Statut: ppublish

Résumé

To compare sequential fluoroscopy guidance with spiral guidance in terms of safety, effectiveness, speed and radiation in interventional whole body procedures. This study was a retrospective analysis of data from the prospective, randomised controlled, multicentre CTNAV2 study. The present analysis included 385 patients: 247 in the sequential group (SEQ) and 138 in the spiral group (SPI). Safety was assessed by the number of major complications. Effectiveness was measured according to the number of targets reached. Data on procedural time and radiation delivered to patients were also collected. There was no significant difference between the two groups (SEQ vs SPI) regarding the success rate (99.6% vs 99.3%, p = 0.680), procedural time (7 min 40 s ± 5 min 48 s vs 7 min 13 s ± 7 min 33 s, p = 0.507), or major complications (2.43% vs 5.8%, p = 0.101). Radiation dose to patients was 84% lower in the sequential group (54.8 ± 51.8 mGy cm vs 352.6 ± 404 mGy cm, p < 0.0001). Sequential CT fluoroscopy-guided whole-body interventional procedures seems to be as safe, effective and fast as spiral guidance, while also yielding a significant decrease in the radiation dose to patients. • Sequential CT fluoroscopy and spiral acquisition are comparable in terms of safety, effectiveness and speed. • Procedural times are comparable despite an increased number of acquisitions in sequential fluoroscopy. • Radiation dose to patients is 84% lower in sequential fluoroscopy compared with spiral CT.

Identifiants

pubmed: 31776742
doi: 10.1007/s00330-019-06490-4
pii: 10.1007/s00330-019-06490-4
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1593-1600

Références

Radiol Med. 2003 Sep;106(3):201-12
pubmed: 14612841
Cardiovasc Intervent Radiol. 2013 Aug;36(4):1055-62
pubmed: 23232857
Eur Radiol. 2020 Feb;30(2):927-933
pubmed: 31444597
AJR Am J Roentgenol. 2009 Apr;192(4):881-6
pubmed: 19304690
AJR Am J Roentgenol. 1992 Nov;159(5):1095-7
pubmed: 1414782
Radiology. 2001 May;219(2):515-20
pubmed: 11323481
Trials. 2017 Jul 6;18(1):306
pubmed: 28683837
AJR Am J Roentgenol. 2007 May;188(5):1187-94
pubmed: 17449757
Eur Radiol. 2006 Jun;16(6):1387-92
pubmed: 16541227
Clin Radiol. 2014 Jul;69(7):709-14
pubmed: 24709093
Eur J Radiol. 2002 Apr;42(1):74-9
pubmed: 12039025
Eur Radiol. 2011 Feb;21(2):232-9
pubmed: 20730613
Radiographics. 2012 Jul-Aug;32(4):1109-19; discussion 1119-20
pubmed: 22786997
AJR Am J Roentgenol. 2000 Apr;174(4):939-42
pubmed: 10749226
Nihon Igaku Hoshasen Gakkai Zasshi. 1994 Oct 25;54(12):1172-4
pubmed: 9261196
Radiology. 2000 Jul;216(1):180-4
pubmed: 10887246
J Comput Assist Tomogr. 1989 Jan-Feb;13(1):182-4
pubmed: 2910943
Radiology. 2001 Jul;220(1):161-7
pubmed: 11425990
Radiologe. 2013 Nov;53(11):974-85
pubmed: 24231823
Clin Radiol. 2002 Mar;57(3):188-92
pubmed: 11952312
Eur Radiol. 2020 Feb;30(2):943-949
pubmed: 31478088
Tech Vasc Interv Radiol. 2010 Sep;13(3):172-5
pubmed: 20723832
Radiology. 1999 Sep;212(3):673-81
pubmed: 10478231
Acad Radiol. 1999 Nov;6(11):687-90
pubmed: 10894072
Eur Radiol. 1999;9(7):1317-20
pubmed: 10460365
AJR Am J Roentgenol. 2011 Jul;197(1):W97-103
pubmed: 21701002
AJR Am J Roentgenol. 2012 Apr;198(4):W347-51
pubmed: 22451571
Br J Radiol. 2001 Dec;74(888):1088-90
pubmed: 11777764
J Vasc Interv Radiol. 2003 Sep;14(9 Pt 2):S199-202
pubmed: 14514818
Clin Imaging. 2018 May - Jun;49:101-105
pubmed: 29207301
Eur J Radiol. 2013 Dec;82(12):2253-7
pubmed: 24050880
Eur J Radiol. 2012 May;81(5):1029-33
pubmed: 21752567

Auteurs

Jean-Philippe Lustig (JP)

Department of Radiology, CHU Besancon, Besancon, 25000, France. jpl_68000@hotmail.com.

Sébastien Aubry (S)

Department of Radiology, CHU Besancon, Besancon, 25000, France.
Nanomedecine Laboratory, INSERM EA4662, Université Bourgogne Franche-Comte, 25000, Besancon, France.

Chrystelle Vidal (C)

Clinical Investigation Center, INSERM CIT808, CHU Besancon, Besancon, 25000, France.

Lionel Pazart (L)

Clinical Investigation Center, INSERM CIT808, CHU Besancon, Besancon, 25000, France.

Alexandre Moreau-Gaudry (A)

Clinical Investigation Center - Innovative Technology INSERM 1406, University Hospital, Grenoble, La Tronche, France.
Laboratory of Techniques for Biomedical Engineering and Complexity Management, University Grenoble Alpes, National Center for Scientific Research, Grenoble, France.

Ivan Bricault (I)

Laboratory of Techniques for Biomedical Engineering and Complexity Management, University Grenoble Alpes, National Center for Scientific Research, Grenoble, France.
Department of Radiology and Medical Imaging, University Hospital, Grenoble, La Tronche, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH